Kjällquist, U.; Acs, B.; Margolin, S.; Karlsson, E.; Kessler, L.E.; Garcia Hernandez, S.; Ekholm, M.; Lundgren, C.; Olsson, E.; Lindman, H.;
et al. Real World Evaluation of the Prosigna/PAM50 Test in a Node-Negative Postmenopausal Swedish Population: A Multicenter Study. Cancers 2022, 14, 2615.
https://doi.org/10.3390/cancers14112615
AMA Style
Kjällquist U, Acs B, Margolin S, Karlsson E, Kessler LE, Garcia Hernandez S, Ekholm M, Lundgren C, Olsson E, Lindman H,
et al. Real World Evaluation of the Prosigna/PAM50 Test in a Node-Negative Postmenopausal Swedish Population: A Multicenter Study. Cancers. 2022; 14(11):2615.
https://doi.org/10.3390/cancers14112615
Chicago/Turabian Style
Kjällquist, Una, Balazs Acs, Sara Margolin, Emelie Karlsson, Luisa Edman Kessler, Scarlett Garcia Hernandez, Maria Ekholm, Christine Lundgren, Erik Olsson, Henrik Lindman,
and et al. 2022. "Real World Evaluation of the Prosigna/PAM50 Test in a Node-Negative Postmenopausal Swedish Population: A Multicenter Study" Cancers 14, no. 11: 2615.
https://doi.org/10.3390/cancers14112615
APA Style
Kjällquist, U., Acs, B., Margolin, S., Karlsson, E., Kessler, L. E., Garcia Hernandez, S., Ekholm, M., Lundgren, C., Olsson, E., Lindman, H., Foukakis, T., Matikas, A., & Hartman, J.
(2022). Real World Evaluation of the Prosigna/PAM50 Test in a Node-Negative Postmenopausal Swedish Population: A Multicenter Study. Cancers, 14(11), 2615.
https://doi.org/10.3390/cancers14112615